We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
instrAction and Protagen Form Strategic Alliance
News

instrAction and Protagen Form Strategic Alliance

instrAction and Protagen Form Strategic Alliance
News

instrAction and Protagen Form Strategic Alliance

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "instrAction and Protagen Form Strategic Alliance"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

instrAction GmbH, Ludwigshafen and Protagen AG , Dortmund, have signed a strategic alliance for the development of customized instrAction ® Phases for downstream processing of biotherapeutics.

“The instrAction® Phases are proprietary synthetic chromatography phases which show excellent performance compared to commonly used matrices for e.g. antibody purification. The unique know-how and expertise of Protagen in GMP-compliant protein analysis and related services will be decisive for the development of a portfolio of new tailor made separation phases for the production of recombinant protein drugs, other biotherapeutics and biosimilars”, comments Dr. Thomas Schwarz, CEO of instrAction.

“In order to exploit the full value of this exciting new protein purification technology and to convince customers from pharma process development and production, it is important to provide convincing data sets from feasibility studies. Protagen has all the tools and know-how to support instrAction on its way to become the leading company in protein separation technology”, underscores Dr. Stefan Müllner, CEO of Protagen.

Advertisement